학술논문

A FIRST IN-HUMAN, MULTICENTER, OPEN-LABEL, DOSE-FINDING PHASE 1 STUDY OF THE IMMUNE STIMULATOR ANTIBODY CONJUGATE NJH395 IN PATIENTS WITH NONBREAST HER2+ADVANCED MALIGNANCIES
Document Type
Journal
Source
JOURNAL FOR IMMUNOTHERAPY OF CANCER; NOV 2020, 8 pA230-pA230, 1p. Supplement: 3
Subject
Language
English
ISSN
20511426